Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 78Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Myelodysplastic Syndromes 59Leukemia, Lymphocytic, Chronic, B-Cell 56Lymphoma, Non-Hodgkin 55Multiple Myeloma 52Hodgkin Disease 52Leukemia 48Lymphoma, Mantle-Cell 43Lymphoma 39Lymphoma, Follicular 38Leukemia, Myelogenous, Chronic, BCR-ABL Positive 38Myeloproliferative Disorders 36Lymphoma, B-Cell, Marginal Zone 36Lymphoma, Large B-Cell, Diffuse 35Burkitt Lymphoma 34Leukemia, Myelomonocytic, Chronic 30Congenital Abnormalities 30Lymphoma, Large-Cell, Immunoblastic 27Waldenstrom Macroglobulinemia 26Leukemia, Myeloid, Accelerated Phase 25Leukemia, Myeloid, Chronic-Phase 23Hematologic Neoplasms 22Blast Crisis 22Primary Myelofibrosis 21Anemia, Refractory, with Excess of Blasts 21Dendritic Cell Sarcoma, Interdigitating 20Lymphoma, T-Cell, Cutaneous 18Lymphoma, Large-Cell, Anaplastic 18Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17

Interventions

fludarabine phosphate 2aldesleukin 2Cyclophosphamide 2fludarabine 1Whole-Body Irradiation 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Melanoma, Experimental × Whole-Body Irradiation × Clear all
NCT00513604 2013-06-03

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
158 enrolled 14 charts
Dermatologic

Melanoma, Melanoma, Experimental, Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡